# clm_09DBC29C37EF

subject: Novo Nordisk (/record/novo-nordisk.md)  
predicate: ceo  
value: Maziar Mike Doustdar  
valid_from: 2025-08-07  
valid_to: null  
published: 2026-02-04  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-08  
cite: AsOf. "Novo Nordisk ceo: Maziar Mike Doustdar", as of 2025-08-07. Claim clm_09DBC29C37EF, https://asof.is/claim/clm_09DBC29C37EF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm.  
checked: 2026-11-08 · its source page states the value and the date  

> On 7 August 2025, Maziar Mike Doustdar succeeded Lars Fruergaard Jørgensen as president and chief executive officer of Novo Nordisk.

What https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm says, word for word.

## Sources

- https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm (primary, SEC EDGAR 20-F, published 2026-02-04)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.